About this trial
We hypothesize that instilling intraperitoneal Marcaine (without epinephrine) at the end of a non-total laparoscopic gynecologic surgery (adnexa only, which includes the ovaries, fallopian tubes, and associated ligaments, vessels, and connective tissue) will result in less pain and reduced opioid use postoperatively.
Eligibility criteria
Qualifiers
Age 18 years and older
Undergoing planned laparoscopic adnexal surgery as a day surgery procedure; The surgical site is the "adnexa" which contains the ovaries, fallopian tubes, and associated ligaments, vessels, and connective tissue. The "adnexa" does not include the uterus.
BMI 55.0 or less
Disqualifiers
Under age 18
Undergoing a non-laparoscopic unplanned surgical procedure Patients having a laparoscopic partial or complete removal of the uterus, a hysterectomy, will NOT be included in this study population for enrollment.
septicemia
severe hemorrhage
Trial design
Treatments tested in this trial
- Normal Saline (0.9% NaCl)
- Marcaine hydrochloride without epinephrine 0.5%